IMS CORE lab teams up with Cristal Therapeutics
Cristal Therapeutics has announced that it has secured a Horizon 2020 grant. This allows the company to further develop the CriPec Nanomedicine Platform. This will be done in collaboration with the IMS CORE lab at Maastricht University’s M4I Division of Imaging Mass Spectrometry.
Cristal Therapeutics is a phase 2 clinical-stage pharmaceutical company developing targeted nanomedicines for the treatment of cancer and other diseases. The ICARUS project will be carried out in close collaboration with the IMS CORE lab at the division of Imaging Mass Spectrometry, where CriPec® nanoparticle microlocalisation and drug release in tumours will be evaluated. Mass spectrometry imaging, technology together with Cristal Therapeutics’ expert team, will provide critical new insights to optimally design CriPec® nanomedicines with the aim of achieve superior therapeutic profiles.
The project at M4I will be led by Dr. Berta Cillero Pastor and by Prof. Ron Heeren.
For more details, read the full article on the Cristal Therapeutics website: http://cristaltherapeutics.com/cristal-therapeutics-awarded-horizon-2020-grant-to-further-develop-the-cripec-nanomedicine-platform/
Also read
-
Europe Day
To celebrate Europe Day on 9 May, FASoS student Lisa travelled to Brussels to meet with five of our inspiring alumni who are currently shaping European policy and advocacy. In this video, they share why Europe Day matters, how it’s celebrated in Brussels, and what the idea of Europe means to them.
-
“The ease with which politicians attack journalists is very worrying”: Can the EU protect press freedom?
May 9 marks Europe Day, which celebrates peace and unity in Europe. Studio Europa sat down with award-winning political cartoonist Emanuele Del Rosso, to discuss the challenges journalists are facing in Europe and beyond.
-
University of Applied Sciences graduates immediately employable in shortage sectors such as healthcare and education
University of Applied Sciences graduates immediately employable in shortage sectors such as healthcare and education.
